As 2026 begins, the global hepatology community is closely monitoring a wave of breakthrough data from Phase II and III trials that aim to permanently correct the ATP7B genetic mutation. Regulatory authorities in the European Union and the United States have recently signaled a willingness to accept biomarker-driven endpoints, such as long-term reduction in non-ceruloplasmin bound copper, to...

The Atherectomy Devices Market is set to expand globally as cardiovascular diseases rise and treatment approaches shift toward minimally invasive methods. Hospitals and cardiac centers are adopting state-of-the-art atherectomy devices that enhance procedural efficiency while minimizing patient discomfort. Innovative technologies, such as laser and orbital atherectomy systems, provide superior...